Tegafur Gimracil And Oteracil

Product Description

Tegoyes 20mg Capsule is a combination chemotherapy medication containing the active constituentsTegafur, Gimeracil, Oteracil. The combination chemotherapy treatment known as S-1 is usedto treat various types of cancer, including gastric, colorectal, breast, and pancreatic cancer.

1. What is Tegafur, Gimeracil, and Oteracil?

   • Tegafur, Gimeracil, and Oteracil are combined together in a medication called S-1. Tegafur is a prodrug, which means it's converted into an active form (5-fluorouracil) in the body. Gimeracil and Oteracil are included to enhance the effects of Tegafur while reducing its toxicity.

2. How does S-1 work?

   • S-1 works by inhibiting the growth of cancer cells. Tegafur is converted into 5-fluorouracil, which disrupts the growth of cancer cells by interfering with their ability to produce DNA and RNA.

3. What types of cancer is S-1 used to treat?

   • S-1 is primarily used in the treatment of advanced gastric cancer, colorectal cancer, and other solid tumors, especially in Japan and some other Asian countries. It may also be used for certain other cancers as determined by a healthcare provider.

4. What are the common side effects of S-1?

   • Common side effects of S-1 may include nausea, vomiting, diarrhea, loss of appetite, fatigue, and hand-foot syndrome (palmar-plantar erythrodysesthesia). These side effects can vary in severity depending on the individual and the dose of medication.

5. How is S-1 taken?

   • S-1 is usually taken orally, as prescribed by a doctor. The dosage and schedule will depend on the specific type and stage of cancer being treated, as well as other individual factors such as overall health and tolerance to the medication.

6. Are there any important precautions or interactions to be aware of?

   • Yes, there are several precautions and potential interactions to be aware of. It's important to inform your doctor about any other medications, supplements, or medical conditions you have before starting S-1 treatment. Additionally, women who are pregnant or breastfeeding should not take S-1 due to potential risks to the fetus or infant.

7. How effective is S-1 in treating cancer?

   • S-1 has been shown to be effective in treating certain types of cancer, particularly when used in combination with other chemotherapy drugs or treatments. However, its effectiveness can vary depending on factors such as the type and stage of cancer, as well as individual patient factors.

8. What should I do if I experience severe side effects while taking S-1?

   • If you experience severe or concerning side effects while taking S-1, it's important to contact your healthcare provider right away. They can assess your symptoms and determine the best course of action, which may include adjusting your dosage, providing supportive care, or discontinuing the medication if necessary.

 

Optimized Anticancer Combination Therapy

Tegafur Gimeracil and Oteracil brings a synergistic approach to chemotherapy. Tegafur serves as the anticancer agent, while Gimeracil enhances its effect by inhibiting its breakdown, and Oteracil minimizes gastrointestinal side effects. This strategic combination is effective for advanced and recurrent colorectal, gastric, and certain other solid tumors, providing healthcare professionals with a comprehensive oral chemotherapy solution.


Rigorous Manufacturing and Compliance Standards

Produced under strict Good Manufacturing Practice (GMP) guidelines, Tegafur Gimeracil and Oteracil tablets ensure reliability and safety for patients. The film-coated tablets are odorless, white to off-white, and come in protective blister packaging, maintaining product integrity throughout its 24-month shelf life.


Maximized Safety and Storage Guidelines

Proper storage of these tablets is crucial. Always keep them under 25C in a cool, dry, and tightly sealed container away from moisture and direct sunlight. This helps preserve their potency and extends shelf life, ensuring patients receive the best therapeutic effects during their course of treatment.